Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8+ PD-1- tumor-infiltrating T cells in PD-L1-enriched tumor microenvironment.
Eissa IR, Mukoyama N, Abdelmoneim M, Naoe Y, Matsumura S, Bustos-Villalobos I, Ichinose T, Miyajima N, Morimoto D, Tanaka M, Fujimoto Y, Sone M, Kodera Y, Kasuya H. Eissa IR, et al. Among authors: kodera y. Int J Cancer. 2021 Jul 1;149(1):214-227. doi: 10.1002/ijc.33550. Epub 2021 Mar 23. Int J Cancer. 2021. PMID: 33687756 Free article.
Clinical experiment of mutant herpes simplex virus HF10 therapy for cancer.
Nakao A, Takeda S, Shimoyama S, Kasuya H, Kimata H, Teshigahara O, Sawaki M, Kikumori T, Kodera Y, Nagasaka T, Goshima F, Nishiyama Y, Imai T. Nakao A, et al. Among authors: kodera y. Curr Cancer Drug Targets. 2007 Mar;7(2):169-74. doi: 10.2174/156800907780058808. Curr Cancer Drug Targets. 2007. PMID: 17346108 Clinical Trial.
A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer.
Nakao A, Kasuya H, Sahin TT, Nomura N, Kanzaki A, Misawa M, Shirota T, Yamada S, Fujii T, Sugimoto H, Shikano T, Nomoto S, Takeda S, Kodera Y, Nishiyama Y. Nakao A, et al. Among authors: kodera y. Cancer Gene Ther. 2011 Mar;18(3):167-75. doi: 10.1038/cgt.2010.65. Epub 2010 Nov 19. Cancer Gene Ther. 2011. PMID: 21102422 Clinical Trial.
Oncolytic herpes virus induces effective anti-cancer immunity against murine colon cancer.
Shirota T, Kasuya H, Kodera Y, Nishikawa Y, Shikano T, Sahin TT, Gewen T, Yamamura K, Fukuda S, Kanzaki A, Yamada S, Fujii T, Sugimoto H, Nomoto S, Takeda S, Nakao A. Shirota T, et al. Among authors: kodera y. Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1482-9. doi: 10.5754/hge11168. Epub 2011 Jul 15. Hepatogastroenterology. 2011. PMID: 21940320
Combination of the tumor angiogenesis inhibitor bevacizumab and intratumoral oncolytic herpes virus injections as a treatment strategy for human gastric cancers.
Deguchi T, Shikano T, Kasuya H, Nawa A, Fujiwara S, Takeda S, Gewen T, Sahin TT, Yamada S, Kanzaki A, Yamamura K, Fujii T, Sugimoto H, Nomoto S, Fukuda S, Nishikawa Y, Kodera Y, Nakao A. Deguchi T, et al. Among authors: kodera y. Hepatogastroenterology. 2012 Sep;59(118):1844-50. doi: 10.5754/hge11566. Hepatogastroenterology. 2012. PMID: 22172413
1,377 results